![Bruno Ohana](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Bruno Ohana is the founder of Biologit.
He held the title of Chief Technology Officer & Director at Biologit.
Actieve functies van Bruno Ohana
Bedrijven | Functie | Begin |
---|---|---|
biologit
![]() biologit Packaged SoftwareTechnology Services Biologit is an Irish technology company that specializes in AI development and dataset labeling for safety surveillance. The company is based in Dublin, Ireland and was founded by Naveen Basar and Bruno Ohana. Biologit combines expertise in pharmacovigilance, pharmaceuticals, biomedical, and artificial intelligence to deliver solutions that unlock safety and efficacy information faster, without compromising on quality, with the goal to keep patients safe. The company's flagship product, Biologit MLM-AI, is a scientific literature monitoring tool for human and veterinary pharmacovigilance, cosmetovigilance, and medical devices powered by artificial intelligence. The tool helps pharmacovigilance professionals focus on screening articles that matter. Nicole Baker has been the CEO since incorporation. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
biologit
![]() biologit Packaged SoftwareTechnology Services Biologit is an Irish technology company that specializes in AI development and dataset labeling for safety surveillance. The company is based in Dublin, Ireland and was founded by Naveen Basar and Bruno Ohana. Biologit combines expertise in pharmacovigilance, pharmaceuticals, biomedical, and artificial intelligence to deliver solutions that unlock safety and efficacy information faster, without compromising on quality, with the goal to keep patients safe. The company's flagship product, Biologit MLM-AI, is a scientific literature monitoring tool for human and veterinary pharmacovigilance, cosmetovigilance, and medical devices powered by artificial intelligence. The tool helps pharmacovigilance professionals focus on screening articles that matter. Nicole Baker has been the CEO since incorporation. | Technology Services |